Fox Chase patients may be eligible to receive third COVID-19 vaccine dose – Read More

MENU

Fox Chase Cancer Center News

September 6, 2021

Fox Chase Cancer Center Welcomes Dr. Lu Chen

PHILADELPHIA (September 6, 2021) – Fox Chase Cancer Center is pleased to announce the hiring of Lu Chen, PhD, who will join the Cancer Signaling and Epigenetics Program and the Cancer Epigenetics Institute (CEI) as an assistant professor.

September 2, 2021

Fox Chase Cancer Center Sponsors Philadelphia Walk to End Colon Cancer

PHILADELPHIA (September 2, 2021)—Fox Chase Cancer Center is proud to announce the 2021 Philadelphia Walk to End Colon Cancer, a family-friendly fundraising event organized by the Colorectal Cancer Alliance.

September 1, 2021

Fox Chase Cancer Center Welcomes Dr. Melissa McShane

PHILADELPHIA (September 1, 2021) – Fox Chase Cancer Center is pleased to announce the hiring of Melissa McShane, MD, who will join the Breast Cancer Medical Oncology Program as an attending physician.

August 31, 2021

Fox Chase Researchers Develop Protocol to Aid in Study of Medulloblastoma

PHILADELPHIA (August 31, 2021)—Researchers at Fox Chase Cancer Center have developed a protocol for procedures to isolate and purify differentiated tumor cells from medulloblastoma in mice and precisely inject these live tumor cells into mouse cerebella.

August 27, 2021

Undergraduate Helps Publish Review That Finds Lower Levels of Trust in HPV Vaccines Among Racial and Ethnic Minorities

PHILADELPHIA (August 27, 2021)—Researchers at Fox Chase Cancer Center recently published a study that found that lower levels of trust in community and healthcare sources plays a role in uptake of the vaccine for the human papillomavirus (HPV) vaccine among racial and ethnic minorities in the United States.

August 24, 2021

Fox Chase Renewed as Clinical Center of Excellence and Named Academic Center of Excellence for Pancreatic Cancer

PHILADELPHIA (August 24, 2021)—Fox Chase Cancer Center and the Marvin and Concetta Greenberg Pancreatic Cancer Institute were recently renewed as a Clinical Center of Excellence and named for the first time as an Academic Center of Excellence for Pancreatic Cancer by the National Pancreas Foundation.

August 23, 2021

Fox Chase Cancer Center Opens New Prostate & Urologic Cancer Program at Fox Chase East Norriton

PHILADELPHIA (August 23, 2021)—Fox Chase Cancer Center is proud to announce the opening of a new Prostate & Urologic Cancer Program at its Fox Chase Cancer Center East Norriton - Hospital Outpatient Center.

August 18, 2021

Fox Chase’s Camille Ragin Awarded SPORE Grant to Examine Racial Differences in Risk for Head and Neck Cancer Patients

PHILADELPHIA (August 18, 2021)—Fox Chase Cancer Center researcher Camille Ragin, PhD, MPH, was recently awarded a Specialized Program of Research Excellence (SPORE) grant of $50,000 for a pilot project examining differences in risk and disease course for Black versus white head and neck cancer patients.

Pages

Connect with Fox Chase